Skip to main content

Colgate-Palmolive Company (CL) Stock Analysis

Buy WaitVALUE-TRAP 2/5High Confidence

Consumer Defensive · Household & Personal Products

Earnings in 1 day (2026-05-01). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait for pullback to $80.15. At $85.26 the A.R:R is 0.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $80.15 (Rr Min Solve Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5.

Colgate-Palmolive manufactures and markets oral, personal, and home care products plus pet nutrition under brands like Colgate, Palmolive, Hill's Science Diet and Hill's Prescription Diet, with products sold in 200+ countries. Oral care (44%), personal care (17%), home care... Read more

$85.26+6.1% A.UpsideScore 5.3/10#6 of 13 Household & Personal Products
Entry $80.15(Rr Min Solve Sticky)Stop $76.86Target $85.83(analyst − 10%)A.R:R 0.1:1Setup A.R:R 1.5:1
Analyst target$95.37+11.9%19 analysts
$85.83our TP
$85.26price
$95.37mean
$79
$105

Wait for pullback to $80.15. At $85.26 the A.R:R is 0.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $80.15 (Rr Min Solve Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Earnings in 1 day. Wait until post-earnings. Score 5.3/10, high confidence.

Passes 4/7 gates (positive momentum, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 1d<=7d. Suitability: moderate.

Val5.2Qual7.5Grw3.9Mom4.5Sent6.1Ins3.8Peer5.2Tech4.0Risk7.15.3OVERALL

Thesis

Rewards
No bull case signals
Risks
Analyst target reached - limited upside remaining
Leverage penalty (D/E 23.4): -1.5
Value-trap signals (2/5): High leverage (D/E 4.5), Material insider selling (33 sells, 0.70% of cap)

Key Metrics

P/E (TTM)32.1
P/E (Fwd)20.7
Mkt Cap$67.8B
EV/EBITDA15.4
Profit Mgn10.5%
ROE497.5%
Rev Growth5.8%
Beta0.33
Dividend2.51%
Rating analysts30

Quality Signals

Piotroski F7/9

Options Flow

P/C0.37bullish
IV44%normal
Max Pain$95+11.4% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMSuppliersingle-source suppliers
    10-K Item 1A: 'we purchase certain key raw and packaging materials from single-source suppliers or a limited number of suppliers'

Material Events(8-K, last 90d)

  • 2026-04-09Item 5.02MEDIUM
    Jennifer Daniels (CLO since 2014) to retire in 2026. Betsy Fishbone (Deputy CLO) appointed CLO effective June 1, 2026. Daniels elected Vice Chair for orderly transition of CLO responsibilities to Fishbone.
    SEC filing →
  • 2026-03-12Item 5.02LOW
    Christopher S. Boerner (CEO and Board Chair of Bristol-Myers Squibb) elected to the Colgate-Palmolive Board effective March 15, 2026. Routine board appointment; no officer departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth
3.9
Low model confidence on this dimension (33%).
GatesA.R:R 0.1 < 1.5@spotEARNINGS PROXIMITY 1d<=7dMomentum 4.5<5.5 (soft — BUY_NOW allowed but watch)Momentum 4.5>=4.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARSuitability: Moderate
RSI
55 · Neutral
↑ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $81.79Resistance $86.33

Price Targets

$77
$80
$86
A.Upside+0.7%
A.R:R0.1:1
Setup A.R:R (at entry)1.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Target reached (0.7% upside)
! Earnings in 1 day - binary event risk
! Reward/Risk 0.1:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-05-01 (1d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CL stock a buy right now?

Wait for pullback to $80.15. At $85.26 the A.R:R is 0.1:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $80.15 (Rr Min Solve Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Earnings in 1 day. Wait until post-earnings. Target $85.83 (+0.7%), stop $76.86 (−10.9%), Setup A.R:R 1.5:1. Score 5.3/10, high confidence.

What is the CL stock price target?

Take-profit target: $85.83 (+6.1% upside). Target $85.83 (+0.7%), stop $76.86 (−10.9%), Setup A.R:R 1.5:1. Stop-loss: $76.86.

What are the risks of investing in CL?

Analyst target reached - limited upside remaining; Leverage penalty (D/E 23.4): -1.5; Value-trap signals (2/5): High leverage (D/E 4.5), Material insider selling (33 sells, 0.70% of cap).

Is CL overvalued or undervalued?

Colgate-Palmolive Company trades at a P/E of 32.1 (forward 20.7). TrendMatrix value score: 5.2/10. Verdict: Buy (Wait for Entry).

What do analysts say about CL?

30 analysts cover CL with a consensus score of 3.7/5. Average price target: $95.

What does Colgate-Palmolive Company do?Colgate-Palmolive manufactures and markets oral, personal, and home care products plus pet nutrition under brands like...

Colgate-Palmolive manufactures and markets oral, personal, and home care products plus pet nutrition under brands like Colgate, Palmolive, Hill's Science Diet and Hill's Prescription Diet, with products sold in 200+ countries. Oral care (44%), personal care (17%), home care (16%), and pet nutrition (23%) make up net sales; roughly two-thirds of net sales originate outside the US.

Related stocks: PG (Procter & Gamble Company (The)) · KMB (Kimberly-Clark Corporation) · UL (Unilever PLC) · CHD (Church & Dwight Company, Inc.) · EL (Estee Lauder Companies, Inc. (T)